A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

by | Aug 26, 2025 | Clinical Trials | 0 comments

​ Conditions: Advanced/Metastatic Solid Tumors

Interventions: Drug: DB-1317

Sponsors: DualityBio Inc.

Not yet recruiting Conditions: Advanced/Metastatic Solid Tumors
Interventions: Drug: DB-1317
Sponsors: DualityBio Inc.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *